Se Ik Kim

45PUBLICATIONS
153CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples cultural determinants of healthCancer diagnosisPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Aug 07, 2026
Reconciling modest median progression-free survival and larger overall survival gains in platinum-resistant ovarian cancer.

|Apr 28, 2026
Factors affecting health-related quality of life in cervical cancer survivors: a multicenter cross-sectional study in Korea.

|Mar 28, 2026
Correction: Ahn et al. Innovative qPCR Algorithm Using Platelet-Derived RNA for High-Specificity and Cost-Effective Ovarian Cancer Detection. Cancers 2025, 17, 1251.

Eunyong Ahn, Se Ik Kim, Sungmin Park

|Mar 16, 2026
Cervical neuroendocrine carcinoma with non-neuroendocrine components has a poorer prognosis than pure neuroendocrine carcinoma.

Sun Min Park, Chel Hun Choi, Kidong Kim

|Mar 03, 2026
Updated clinical practice guidelines for human papillomavirus vaccination: the Korean Society of Gynecologic Oncology recommendations.

Hyunji Lim, Se Ik Kim, Kyung-Jin Min

|Jan 09, 2026
Phase II randomized study of first-line carboplatin and paclitaxel in combination with pembrolizumab, followed by maintenance pembrolizumab alone or with nesuparib, in mismatch-repair proficient, advanced or recurrent endometrial cancer (PENELOPE).

Se Ik Kim, Hyun-Woong Cho, Chel Hun Choi

Pageof 8

Frequent Collaborators

11 joint publications

Jae-Weon Kim

11 joint publications

Yong-Sang Song

10 joint publications

Maria Lee

8 joint publications

Myong Cheol Lim